ChemSpider 2D Image | mobocertinib succinate | C36H45N7O8

mobocertinib succinate

  • Molecular FormulaC36H45N7O8
  • Average mass703.785 Da
  • Monoisotopic mass703.332947 Da
  • ChemSpider ID84455482

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester, butanedioate (1:1) [ACD/Index Name]
Acide succinique - 2-{[5-(acryloylamino)-4-{[2-(diméthylamino)éthyl](méthyl)amino}-2-méthoxyphényl]amino}-4-(1-méthyl-1H-indol-3-yl)-5-pyrimidinecarboxylate d'isopropyle (1:1) [French] [ACD/IUPAC Name]
Bernsteinsäure -isopropyl-2-{[5-(acryloylamino)-4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxyphenyl]amino}-4-(1-methyl-1H-indol-3-yl)-5-pyrimidincarboxylat (1:1) [German] [ACD/IUPAC Name]
Exkivity [Trade name]
mobocertinib succinate [USAN]
Succinic acid - isopropyl 2-{[5-(acryloylamino)-4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxyphenyl]amino}-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate (1:1) [ACD/IUPAC Name]
2389149-74-8 [RN]
  • Miscellaneous

    • Therapeutical Effect:

      To treat locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations FDA Exkivity

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement